Skip to main content
. 2015 Jun 3;92(Suppl 6):51–58. doi: 10.4269/ajtmh.14-0394

Table 4.

Drug information and results of quality tested by HPLC and dissolution

Drug name Brand name (if applicable) Strength (mg) Pack size Manufacturer Country of manufacture Batch number Manufacturing date Expiry date No. of samples Dissolution test (compliance with tolerance limits) HPLC (contained stated amount of active ingredient)
Artesunate Not stated 50 36 Aurochem Pharma India AFJ35A /08C01 03/2008 02/2011 2 Not undertaken Yes
Artesunate Falcigo 50 32 Zydus Adila Healthcare India ZHJ2175 06/2009 06/2011 1 Not undertaken Yes
Sulfadoxine/Pyrimethamine Fansidar 500/25 3 Efroze Chemical Industries Pakistan H003 07/2007 06/2010 2 No Yes
Sulfadoxine/Pyrimethamine Fansidar 500/25 14 Roche Pharm. Pakistan 000267 01/2009 01/2012 2 No Yes
Sulfadoxine/Pyrimethamine Fansidar 500/25 14 Roche Pharm. Pakistan 755 10/2005 10/2010 2 No Yes
Sulfadoxine/Pyrimethamine Fansidar 500/25 14 Roche Pharm. Pakistan P01075 02/2008 03/2011 2 No Yes
Sulfadoxine/Pyrimethamine Maladar 500/25 15 Roche Pharm. Pakistan P001103 01/2009 01/2013 1 No Yes
Quinine Howards 300 99 Howards Pakistan 70321 05/2007 05/2012 1 No Yes
Quinine Howards 300 99 Howards Pakistan 80576 08/2008 08/2013 1 No Yes
Quinine Howards 300 99 Howards Pakistan 70322 05/2007 05/2012 1 No Yes
Chloroquine Not stated 150 30 Pars Darou Iran 7800 12/2006 11/2010 1 Yes Yes
Chloroquine Not stated 150 30 Khawarazwy Iran n/a 07/2006 07/2010 1 Yes Yes
Chloroquine Not stated 150 30 Sanofi-Aventis Pakistan U060 05/2008 04/2012 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan N165 12/2006 11/2010 2 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan U067 06/2008 05/2012 2 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan C014 01/2009 12/2012 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan U007 01/2008 12/2011 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan N165 12/2007 11/2011 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan B178 09/2007 08/2011 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan U067 06/2008 05/2012 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan U195 06/2008 05/2012 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan C049 02/2009 01/2013 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan C098 02/2009 01/2013 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan C085 04/2009 03/2013 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan C014 12/2008 11/2012 2 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan HC143 07/2009 06/2013 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan C127 06/2009 05/2013 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan B193 10/2007 09/2011 1 Yes Yes
Chloroquine Nivaquine-P 250 20 Sanofi-Aventis Pakistan U167 10/2008 09/2012 1 Yes Yes
Chloroquine Nivaquine-P 250 30 Sanofi-Aventis Pakistan U046 05/2008 04/2012 3 Yes Yes
Complaint with USP tolerance limits 25/37 (68%) 40/40
Noncompliant with USP tolerance limits 12/37 (32%) 0
Total 37 40

HPLC = high-performance liquid chromatography; USP = U.S. Pharmacopeia.

Samples of chloroquine, sulfadoxine/pyrimethamine, and quinine were made by the same manufacturer but were from different batches as denoted by the batch number.